| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/13/2000 | CA2345375A1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure |
| 04/13/2000 | CA2345240A1 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 04/12/2000 | EP0992579A1 Stem cell factor |
| 04/12/2000 | EP0991660A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/12/2000 | EP0991638A1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS |
| 04/12/2000 | EP0991630A1 Crystalline roxifiban |
| 04/12/2000 | EP0991625A2 Inhibitors of factor xa with a neutral p1 specificity group |
| 04/12/2000 | EP0991624A1 Phenylalkyl derivatives with thrombin-inhibiting effect |
| 04/12/2000 | EP0991416A1 A universally applicable blood plasma |
| 04/12/2000 | CN1250445A Sulfamide-metalloprotease inhibitors |
| 04/12/2000 | CN1249947A Compound hemostatic |
| 04/12/2000 | CN1051317C Displacement chromatography process and purified hemoglobin product |
| 04/12/2000 | CN1051236C 止血散 Hemostatic Powder |
| 04/11/2000 | US6048967 Blood compound associated with a nitroxide compound to prevent or alleviate the side effects of oxygen stress |
| 04/11/2000 | US6048966 Preventing blood loss using fibrinogenas a seal; incubation of fibrinogen with splitting enzyme with subseqent application of digested peptides to desired site of action |
| 04/11/2000 | US6048891 Administering mixtures with 6-hydroxy-2,7,8-trimethyl-chroman-2-propanoic acid for treatment of cardiovascular and kidney disorders |
| 04/11/2000 | US6048880 Therapy for cytokine sensitive diseases |
| 04/11/2000 | US6048875 Benzothiophene, benzofuran and indole compounds |
| 04/11/2000 | US6048874 Parenteral metolazone formulations |
| 04/11/2000 | US6048724 Producing mammalian transfected cell strain which expresses exogenous dna encoding erythropoietin and glucagons; for prevention or treatment of a condition in which insulin production or glucagon function is defective |
| 04/11/2000 | US6048524 In vivo production and delivery of erythropoietin for gene therapy |
| 04/06/2000 | WO2000018969A1 Methods to selectively inactivate viruses in biological compositions |
| 04/06/2000 | WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | WO2000018885A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 04/06/2000 | WO2000018796A2 Secretory protein- zsig48 |
| 04/06/2000 | WO2000018762A1 Thrombin inhibitors |
| 04/06/2000 | WO2000018744A1 Oxazole compounds as prostaglandin e2 agonists or antagonists |
| 04/06/2000 | WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors |
| 04/06/2000 | WO2000018436A1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 04/06/2000 | WO2000018424A1 Use of substances with oxytocin activity in order to create cell regeneration |
| 04/06/2000 | WO2000018421A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 04/06/2000 | WO2000018418A2 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 04/06/2000 | WO2000018412A1 Solid phase quenching systems |
| 04/06/2000 | WO2000018404A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | WO2000018398A1 Pharmaceutically active compounds and methods of use thereof |
| 04/06/2000 | WO2000018352A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | WO2000001704A3 Benzimidazoles, production thereof and use thereof as medicaments |
| 04/06/2000 | WO1999058699A3 Transgenic plant-derived human blood coagulation factors |
| 04/06/2000 | DE19845153A1 Imidazo[4,5]-pyridin-4-on-derivate Imidazo [4,5] pyridin-4-one derivatives |
| 04/06/2000 | CA2345641A1 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | CA2345474A1 Oxazole compounds as prostaglandin e2 agonists or antagonists |
| 04/06/2000 | CA2345273A1 Pharmaceutically active compounds and methods of use thereof |
| 04/06/2000 | CA2345243A1 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 04/06/2000 | CA2345230A1 Methods to selectively inactivate viruses in biological compositions |
| 04/06/2000 | CA2345156A1 Solid phase quenching systems |
| 04/06/2000 | CA2344712A1 Secretory protein- zsig48 |
| 04/06/2000 | CA2344653A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 04/06/2000 | CA2344050A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | CA2343934A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | CA2343716A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 04/06/2000 | CA2343109A1 Thrombin inhibitors |
| 04/06/2000 | CA2340454A1 Benzamide derivatives and their use as cytokine derivatives |
| 04/06/2000 | CA2285151A1 Novel heparin binding peptides |
| 04/05/2000 | EP0990034A1 Anti-gpiib/iiia recombinant antibodies |
| 04/05/2000 | EP0990031A2 Tumor necrosis factor receptor 5 |
| 04/05/2000 | EP0990002A1 Dextran derivatives, preparation method and applications as medicine with specific biological action |
| 04/05/2000 | EP0989982A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 04/05/2000 | EP0989975A1 Oxazole compounds useful as pge2 agonists and antagonists |
| 04/05/2000 | EP0989854A1 Compositions useful as fibrin sealants |
| 04/05/2000 | EP0989849A2 Therapeutic nanospheres |
| 04/05/2000 | EP0777740B1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0777739B1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0766664B1 Metalloproteinase inhibitors |
| 04/05/2000 | EP0750631B1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 04/05/2000 | CN1051020C Method for preparing venin cream |
| 04/05/2000 | CN1051017C Thrombus dissolving 'Guiluchun' |
| 04/04/2000 | US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors |
| 04/04/2000 | US6046340 Imidazole containing pseudodipeptide product and compositions containing the same |
| 04/04/2000 | US6046318 Isolated cdna which encodes a protein having one or more cysteine containing domains; for diagnosis, therapy, recombinant production, and as probes to isolate related proteins in other species and organisms |
| 04/04/2000 | US6046237 Non-β-oxidizable fatty acid analogues, their uses as therapeutic active medicaments |
| 04/04/2000 | US6046198 Hemoregulatory compounds |
| 04/04/2000 | US6046197 Non-peptide amide compounds; stimulate hematopoiesis and may be useful for treatment of viral, fungal and bacterial infectious diseases |
| 04/04/2000 | US6046022 Methods and compositions employing red rice fermentation products |
| 04/04/2000 | CA2006975C Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith |
| 04/04/2000 | CA2002540C Dna sequence coding for the human ix factor or a similar protein, expression vector, transformed cells, process for the preparation of ix factor and products obtained |
| 04/04/2000 | CA1340942C Processes for the treatment of vascular disease |
| 03/30/2000 | WO2000017375A2 Method to treat haemophilia by in vivo gene therapy with retroviral vectors |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/30/2000 | WO2000017354A1 Human isre-binding protein |
| 03/30/2000 | WO2000017328A2 Fibrils |
| 03/30/2000 | WO2000017222A1 31 human secreted proteins |
| 03/30/2000 | WO2000017204A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 03/30/2000 | WO2000017184A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors |
| 03/30/2000 | WO2000017175A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017167A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 03/30/2000 | WO2000016801A1 Methods of downmodulating the immune response to therapeutic proteins |
| 03/30/2000 | WO2000016773A1 Pharmaceutical composition containing an angiotensin ii at1 receptor antagonist and an antiplatelet agent |
| 03/30/2000 | WO2000016767A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 03/30/2000 | WO2000016760A2 New use of prostaglandin e2 antagonists |
| 03/30/2000 | WO1999066918A9 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 03/30/2000 | WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 03/30/2000 | DE19845830A1 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln Aminoalkyl-3,4-dihydroquinoline derivatives and their use in medicaments |
| 03/30/2000 | CA2345311A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors |
| 03/30/2000 | CA2344657A1 Human isre-binding protein |
| 03/30/2000 | CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 03/30/2000 | CA2344100A1 31 human secreted proteins |
| 03/30/2000 | CA2343916A1 Methods of downmodulating the immune response to therapeutic proteins |
| 03/30/2000 | CA2343360A1 Human cytoskeleton associated proteins |